CBLI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CBLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cleveland BioLabs's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2021 was $0.00 Mil.
The historical data trend for Cleveland BioLabs's Long-Term Capital Lease Obligation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cleveland BioLabs Annual Data | |||||||||||||||||||||
Trend | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | |||||||||||
Long-Term Capital Lease Obligation | Get a 7-Day Free Trial | - | - | - | - | - |
Cleveland BioLabs Quarterly Data | ||||||||||||||||||||
Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | |
Long-Term Capital Lease Obligation | Get a 7-Day Free Trial | - | - | - | - | - |
Cleveland BioLabs (NAS:CBLI) Long-Term Capital Lease Obligation Explanation
Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.
Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:
1. Ownership of the asset is transferred to the lessee at the end of the lease term;Thank you for viewing the detailed overview of Cleveland BioLabs's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.
Christopher Zosh | officer: Vice President of Finance | C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO NY 14203 |
Ivan Fedyunin | director | 73 HIGH STREET, BUFFALO NY 14203 |
John Edward Szydlo | officer: Principal Financial Officer | 73 HIGH STREET, BUFFALO NY 14203 |
Randy S. Saluck | director | C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO NY 14203 |
Alexander Andryushechkin | director | 73 HIGH STREET, BUFFALO NY 14203 |
Daniil Talyanskiy | director | 73 HIGH STREET, BUFFALO NY 14203 |
Alexey Nechaev | director | 73 HIGH STREET, BUFFALO NY 14203 |
Lea Verny | director | 73 HIGH STREET, BUFFALO NY 14203 |
Tatiana Levina | director | 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031 |
Ivan Persiyanov | director | 4 SADOVNICHESKAYA ST, MOSCOW 1Z 115035 |
Anna Evdokimova | director | 9-96 UNIVERSITETSKIY PROSPEKT, MOSCOW 1Z 119296 |
Yulia Lebedina | director | 5 MALYSHEVA STREET, FLAT 7, MOSCOW 1Z 109129 |
Konstantin Gorshkov | director | 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031 |
Natalia Saraeva | director | 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031 |
Natalia Khudyk | director | 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031 |
From GuruFocus
By ACCESSWIRE AccessWire • 04-12-2019
By ACCESSWIRE AccessWire • 04-12-2019
By Business Wire Business Wire • 11-04-2020
By PRNewswire PRNewswire • 10-22-2020
By Marketwired Marketwired • 10-21-2020
By ACCESSWIRE ACCESSWIRE • 02-19-2021
By [email protected] [email protected] • 06-01-2020
By Marketwired Marketwired • 02-17-2021
By PRNewswire PRNewswire • 10-23-2020
By ACCESSWIRE ACCESSWIRE • 10-20-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.